Topic: psoriatic arthritis

Pfizer sign

3. Pfizer

Pfizer totted up a list of accomplishments and milestones in 2018, besides the fact that it managed to eke out growth of about 2% for the year. It reorganized into three business units, for instance, reviving talk of an eventual generics spinoff and setting up its consumer health business for easier disposal.
Eli Lilly

11. Eli Lilly

In CEO David Ricks' first year running the show, Eli Lilly posted nearly 8% revenue growth to $22.87 billion, beating the high end of its own guidance of $22.7 billion set in the third-quarter report.